Article info

Original research
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA

Authors

  1. Correspondence to Dr Yevgeniy R Semenov; YSEMENOV{at}mgh.harvard.edu
View Full Text

Citation

Kalinich M, Murphy W, Wongvibulsin S, et al
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA

Publication history

  • Accepted March 9, 2021
  • First published March 31, 2021.
Online issue publication 
March 31, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.